Biotechnology CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer May 16, 2022
Biotechnology Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Axsome Therapeutics, Inc. (AXSM) Investors of Class Action and Encourages Investors to Contact the Firm May 16, 2022
Biotechnology ChemoCentryx to Present at the H.C. Wainwright Global Investment Conference May 16, 2022
Biotechnology Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs May 16, 2022